Sermonix Pharmaceuticals

Olema Oncology

This biopharmaceutical company develops targeted therapies, including palazestrant, for women diagnosed with estrogen receptor-positive breast cancer and other solid tumours.

Galera

This biopharmaceutical company develops small-molecule therapies to reduce the side effects of radiotherapy and improve treatment outcomes for patients with advanced breast cancer.

Acrivon Therapeutics

This biopharmaceutical company develops precision oncology medicines and proteomics-based companion diagnostics for cancer patients.

TESARO

This biopharmaceutical company develops and commercialises oncology medicines, including treatments for ovarian and endometrial cancers, for patients undergoing chemotherapy or with specific genetic mutations.

TORL BioTherapeutics

This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.

Avenzo Therapeutics

This biotechnology company develops oncology therapies targeting solid tumours and metastatic breast cancer for patients with high unmet medical needs.

Peloton Therapeutics

This biopharmaceutical company develops small molecule oral medicines for patients with renal cell carcinoma and other forms of cancer.

Chimerix

This biopharmaceutical company develops medicines for oncology and viral diseases for patients with life-threatening conditions.